FDA Sets February Meeting for J&J Drug

According to the Associated Press, government advisers will meet in late February to review Johnson & Johnson''s antibiotic to treat skin infections.

The Food and Drug Administration''s panel of outside antibiotic experts will consider approval of the company''s ceftobiprole at a Feb. 28 meeting, according to a notice posted to the agency''s Web site. The FDA is not required to follow the panel''s recommendations, though it often does.